Holen Sie sich die Stockscreener-App
0.00
100.00%
-18.20
Finanzdaten der Reneo Pharmaceuticals Inc-Aktie (RPHM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
61.75%
9.564
|
25.01 | 20.89 | 21.04 | 16.12 |
| Operating Income/Loss |
61.75%
-9.564
|
-25.01 | -20.89 | -21.04 | -16.12 |
| Income/Loss From Continuing Operations Before Tax |
64.23%
-8.426
|
-23.55 | -19.20 | -19.53 | -15.11 |
| Income/Loss From Continuing Operations After Tax |
64.23%
-8.426
|
-23.55 | -19.20 | -19.53 | -15.11 |
|
Net Income/Loss
|
64.23%
-8.426
|
-23.55 | -19.20 | -19.53 | -15.11 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,389%
33.42
|
0.9578 | 33.81 | 30.22 | 25.04 |
| Diluted Average Shares |
3,389%
33.42
|
0.9578 | 33.81 | 30.22 | 25.04 |
| Basic Earnings Per Share |
64.79%
-0.25
|
-0.71 | -0.57 | -0.65 | -0.60 |
| Diluted Earnings Per Share |
64.79%
-0.25
|
-0.71 | -0.57 | -0.65 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):